| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 16.354 | 108.288 | 181.142 | 170.789 | 201.976 |
| Total Income - EUR | - | - | - | - | - | 16.658 | 125.454 | 186.532 | 177.731 | 207.609 |
| Total Expenses - EUR | - | - | - | - | - | 27.750 | 101.406 | 160.362 | 156.808 | 176.218 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -11.092 | 24.048 | 26.170 | 20.923 | 31.390 |
| Net Profit/Loss - EUR | - | - | - | - | - | -11.092 | 23.018 | 24.377 | 19.442 | 25.390 |
| Employees | - | - | - | - | - | 4 | 4 | 4 | 4 | 3 |
Check the financial reports for the company - Dr. Timuş Tudor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 41.441 | 44.867 | 40.530 | 47.388 | 61.937 |
| Current Assets | - | - | - | - | - | 9.420 | 9.463 | 16.852 | 5.139 | 3.184 |
| Inventories | - | - | - | - | - | 0 | 364 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 253 | 0 | 0 | 80 |
| Cash | - | - | - | - | - | 9.420 | 8.847 | 16.852 | 5.139 | 3.104 |
| Shareholders Funds | - | - | - | - | - | -11.050 | 12.213 | 24.417 | 30.601 | 25.430 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 61.911 | 17.939 | 12.261 | 4.824 | 26.202 |
| Income in Advance | - | - | - | - | - | 0 | 24.178 | 20.704 | 17.103 | 13.489 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Timuş Tudor S.r.l.